Robertson Stephens Wealth Management, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Robertson Stephens Wealth Management, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$136,000
-55.7%
133,840
-39.9%
0.02%
-59.5%
Q2 2021$307,000
-14.7%
222,619
+4.9%
0.04%
-36.2%
Q1 2021$360,000
+37.4%
212,238
+0.1%
0.06%
+5.5%
Q4 2020$262,000
-13.0%
212,0520.0%0.06%
-25.7%
Q3 2020$301,000
+144.7%
212,052
+108.0%
0.07%
+111.4%
Q2 2020$123,000
-0.8%
101,965
-2.7%
0.04%
-16.7%
Q1 2020$124,000104,7950.04%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Perceptive Advisors 12,528,120$38,210,0001.53%
Cormorant Asset Management, LP 850,000$2,593,0000.41%
Palo Alto Investors LP 1,656,644$5,053,0000.24%
Granahan Investment Management 1,745,604$5,324,0000.16%
Spark Investment Management LLC 318,500$980,0000.13%
Opus Point Partners Management, LLC 57,747$176,0000.10%
SHEPHERD KAPLAN KROCHUK, LLC 76,472$233,0000.06%
Joel Isaacson & Co., LLC 70,660$216,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$229,0000.05%
Cornerstone Capital, Inc. 59,200$181,0000.04%
View complete list of ACELRX PHARMACEUTICALS INC shareholders